Company Growth (employees)
Medtronic was founded in 1949 and is headquartered in Minneapolis, US
Key People at Medtronic
Omar Ishrak
Chairman and CEO
Richard E. Kuntz
Senior Vice President and Chief Scientific, Clinical and Regulatory Officer
Carol Surface
SVP and Chief Human Resources Officer
Medtronic Office Locations
Medtronic has offices in Minneapolis, Dublin, Singapore, Moscow and in 50 other locations
Minneapolis, US (HQ)
710 Medtronic Parkway
Tolochenaz, CH
Route du Molliau 31, Case Postale
Mumbai, IN
#1241, Solitaire Corporate Park, Building 12, Ghatkopar Andheri Link Road, Andheri
Miami, US
Doral Corporate Centre II, 3750 NW 87th Avenue, Suite 700
Beijing, CN
Beijing Rep. Office Suite 1805-1812 E1 Tower Oriental Plaza, No.1 East Chang An Ave., Dong Cheng District
Moscow, RU
Naberezhnaya Tower C, Presnenskaya Naberezhnaya,10
Medtronic Data and Metrics
Medtronic Financial Metrics
Medtronic's revenue was reported to be $29.7 b in FY, 2017
USD
Revenue (FY, 2017) | 29.7 b |
Revenue growth (FY, 2016 - FY, 2017), % | 3% |
Gross profit (FY, 2017) | 20.4 b |
Gross profit margin (FY, 2017), % | 69% |
Net income (FY, 2017) | 4 b |
EBIT (FY, 2017) | 5.3 b |
Market capitalization (21-Sep-2017) | 109.4 b |
Cash (28-Apr-2017) | 5 b |
EV | 130.4 b |
Medtronic's current market capitalization is $109.4 b.
| USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
|---|---|---|---|---|
Revenue | 17 b | 20.3 b | 28.8 b | 29.7 b |
Revenue growth, % | 19% | 42% | 3% | |
Cost of goods sold | 4.3 b | 6.3 b | 9.1 b | 9.3 b |
Gross profit | 12.7 b | 14 b | 19.7 b | 20.4 b |
| USD | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 |
|---|---|---|---|---|---|---|---|
Revenue | 7.3 b | 7.1 b | 6.9 b | 7.2 b | 7.3 b | 7.3 q | |
Cost of goods sold | 2.5 b | 2.2 b | 2.1 b | 2.3 b | 2.3 b | 2.3 q | |
Gross profit | 4.8 b | 4.9 b | 4.8 b | 4.9 b | 5 b | 5 q | |
Gross profit Margin, % | 66% | 69% | 69% | 68% | 68% | 69% |
| USD | Y, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
|---|---|---|---|---|
Cash | 13.2 m | 4.8 b | 186.4 m | 5 b |
Accounts Receivable | 17.1 m | |||
Inventories | 1.7 b | 3.5 b | 3.5 b | 3.3 b |
Current Assets | 21.2 b | 30.8 b | 23.6 b | 24.9 b |
| USD | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 |
|---|---|---|---|---|---|---|---|
Cash | 46 k | 3 b | 2.4 b | 2.7 b | 3.1 b | 3 b | 2.8 b |
Inventories | 3.4 b | 3.5 b | 3.5 b | 3.6 b | 3.7 b | 3.7 b | |
Current Assets | 46 k | 29.1 b | 28.7 b | 27.6 b | 23.5 b | 22.5 b | 22.4 b |
PP&E | 4.7 b | 4.7 b | 4.6 b | 4.8 b | 4.9 b | 4.9 b |
| USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
|---|---|---|---|---|
Net Income | 3.1 b | 2.7 b | 3.5 b | 4 b |
Depreciation and Amortization | 349 m | 1.3 b | 2.8 b | 2 b |
Accounts Receivable | (70 m) | (413 m) | (435 m) | (75 m) |
Inventories | (39 m) | (282 m) | (186 m) |
| USD | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 |
|---|---|---|---|---|---|---|---|
Net Income | (37.1 m) | 820 m | 520 m | 1.1 b | 929 m | 2 b | 2.9 b |
Depreciation and Amortization | 481 m | 483 m | 484 m | 737 m | 1.5 b | 2.2 b | |
Accounts Receivable | 196 m | (89 m) | 18 m | ||||
Inventories | 3.4 b | 3.5 b | 3.5 b | (101 m) | (187 m) | (261 m) |
| USD | Y, 2017 |
|---|---|
EV/EBIT | 24.5 x |
EV/CFO | 18.9 x |
Revenue/Employee | 337.6 k |
Debt/Equity | 0.5 x |
Debt/Assets | 0.3 x |
Financial Leverage | 2 x |
Medtronic Operating Metrics
Medtronic's Patients Served was reported to be 65 m in FY, 2016
| FY, 2014 | FY, 2015 | FY, 2016 | |
|---|---|---|---|
Patents Issued | 27 k | 53 k | 45 k |
Countries | 160 | 160 | |
Patients Served | 65 m |
Medtronic Market Value History
Medtronic's employees are reported to be approximately 49% female and 51% male.
Medtronic Median Salaries
Source: 602 public H-1B filings from Medtronic
Market Position of Medtronic
Traffic Overview of Medtronic
Medtronic Online and Social Media Presence
Medtronic News and Updates
April 18, 2017
2 small firms are going to make a killing on a $6.1 billion deal
Two of the usual suspects played a role in setting up Cardinal Health’s $6.1 billion acquisition of Medtronic’s medical supplies business. But two smaller firms also got in on the action.
Goldman Sachs and Perella Weinberg are advising Cardinal Health on the deal, while Pip…
February 13, 2017
Why Medtronic Is One Of The Most Innovative Companies Of 2017
Thanks to a new system, some diabetes patients can spend less time managing their health.
Thanks to a new system, some diabetes patients can spend less time managing their health.The $100 billion medical device maker Medtronic announced in September that it had received FDA app…